VEGFA and glioblastoma: Monoclonal antibodies against VEGF such as the FDA-approved bevacizumab (Avastin) are used clinically in newly diagnosed and recurrent GBM [90,91], metastatic breast cancer [92], and metastatic colorectal cancer [93].